Oxytocin nasal spray may help people with borderline personality disorder engage in self-compassion meditation

A quick spray of oxytocin could make a big difference in therapy. New research suggests the hormone helps individuals with borderline personality disorder overcome severe self-criticism and successfully visualize comforting mental images during self-compassion meditation.

New research published in Psychiatry Research suggests that a nasal spray of the hormone oxytocin may help individuals with borderline personality disorder get more out of compassion-based meditation. The study provides evidence that oxytocin specifically improves a person’s ability to create and hold onto comforting mental images during these exercises. These early findings suggest a potential new way to support people who often find self-compassion practices difficult or uncomfortable.

Borderline personality disorder, commonly known as BPD, is a mental health condition characterized by intense emotional instability. People with BPD often experience severe difficulties in their relationships, deep struggles with their self-image, and sudden impulsive behaviors. These features make it exceptionally hard for individuals to regulate their emotions on a daily basis.

A major feature of this disorder involves high levels of self-criticism and shame. This tends to result in a habit of self-invalidation, where individuals constantly dismiss, minimize, or punish their own emotional experiences. This pattern of self-invalidation often stems from childhood experiences in environments where a person’s private emotions were ignored or rejected.

“Some individuals have difficulty feeling valued and exhibit a self-critical attitude, which constitutes a transdiagnostic variable that is both a